Compare Costco Wholesale Corporation (COST) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Costco Wholesale Corporation vs Cassava Sciences Inc — how do they compare? Costco Wholesale Corporation trades at $921.16 (market cap $408.78B), while Cassava Sciences Inc trades at $1.09 (market cap $52.66M). The key difference: Costco Wholesale Corporation is far larger — about 7762.6× Cassava Sciences Inc's market cap, and Costco Wholesale Corporation pays a 0.64% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| COST | FLNA | |
|---|---|---|
Market Cap | $408.78B | $52.66M |
Sector | Consumer Staples | Health |
52-Week High | $1.09K | $4.64 |
52-Week Low | $849.63 | $1.09 |
Enterprise Value | $396.92B | -$33.92M |
Dividend Yield | 0.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Costco (COST) trades at $926.43, up 1.11% with strong fundamentals including 11.3% March sales growth and consistent earnings beats. The stock faces technical headwinds with bearish moving averages but maintains solid profitability with $8.1B net income and expanding margins. Recent membership fee increases and warehouse expansion support long-term growth, though high valuation multiples present near-term pressure.
Outlook remains positive with analyst consensus at $1,120 price target (65% buy ratings), but investors should monitor valuation sustainability amid technical weakness. Key risks include competitive pressures and economic sensitivity, while institutional accumulation and strong cash flow generation provide fundamental support.
FLNA trades at $1.15, down 2.54% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company continues to report losses, with a net income of -$90.97M in 2025 and negative cash flow, though it has beaten EPS estimates for the last three quarters. Recent news highlights ongoing development in its TSC-related epilepsy therapies.
Despite consistent earnings beats, FLNA's negative profitability and cash burn pose significant risks. Analyst sentiment is positive with a 66.7% buy rating, but the stock's outlook depends heavily on clinical success and future funding. Investors should weigh the high-risk, high-reward nature of this biotech play.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
